title: Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Wendling
authors.forename: Vincent
authors.initials: V
authors.lastname: Descamps
authors.forename: Maggy
authors.initials: M
authors.lastname: Grossin
authors.forename: Patrick
authors.initials: P
authors.lastname: Marcellin
authors.forename: Patrick
authors.initials: P
authors.lastname: Le Bozec
authors.forename: Stéphane
authors.initials: S
authors.lastname: Belaich
authors.forename: Béatrice
authors.initials: B
authors.lastname: Crickx
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000009:adverse effects*; D012507:Sarcoidosis / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin